• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A25-25/C95-O20
Device Problem Stretched (1601)
Patient Problem Failure of Implant (1924)
Event Date 09/26/2017
Event Type  Injury  
Manufacturer Narrative
At the completion of the clinical evaluation, based on the information received, there were evidence to support the reported endoleak.It was confirmed that patient had an el3a (mfg report mdr: 2031527-2017-00542); a complete component separation; and a secondary endovascular intervention.In addition, a stent cage dilation of the cuff and main body stent (mfg report mdr: 2031527-2017-00542),( 24% and 36% respectively).The most likely cause of the loss of seal and implant separation was the use of strata material in combination[ due to the presence of stent cage dilation] with severe aortic remodeling (anatomy).The patient's disposition post repair could not be ascertained; there were no further reports of negative patient sequelae.The review of manufacturing lot confirmed all devices met specifications prior to release.The lot usage history shows that no other units from the affected lots have been involved in any similar complaints at this time.No device will be returned as the device remains implanted in the patient.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.
 
Event Description
The patient was initially implanted with a bifurcated and suprarenal device in 2012.On (b)(6) 2017, the patient presented his recent ct to the physician.An endoleak type iiia with complete component separation was observed.The physician elected to reline with a vela cuff and ovation to successfully resolve the leak.No additional patient sequela has been reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key7165604
MDR Text Key96411059
Report Number2031527-2018-00007
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date08/31/2012
Device Model NumberA25-25/C95-O20
Device Catalogue NumberF00395
Device Lot NumberW11-4468-044
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/27/2017
Initial Date FDA Received01/04/2018
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/28/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BIFURCATED STENT GRAFT LOT W11-5098-013
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-